14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $27.14 $33.02 Thursday, 25th Apr 2024 AGIO stock ended at $31.67. During the day the stock fluctuated 3.32% from a day low at $31.22 to a day high of $32.25.
90 days $22.23 $35.48
52 weeks $19.80 $35.48

Historical Agios Pharmaceuticals prices

Date Open High Low Close Volume
Jan 08, 2024 $23.04 $24.46 $22.65 $24.45 618 184
Jan 05, 2024 $23.17 $23.24 $22.43 $23.14 684 126
Jan 04, 2024 $24.14 $24.33 $23.35 $23.47 885 824
Jan 03, 2024 $23.58 $25.43 $21.79 $24.02 2 589 383
Jan 02, 2024 $22.20 $23.22 $22.06 $22.83 401 995
Dec 29, 2023 $22.73 $22.73 $22.22 $22.27 661 740
Dec 28, 2023 $22.78 $23.18 $22.43 $22.79 447 681
Dec 27, 2023 $23.09 $23.12 $22.34 $22.83 480 214
Dec 26, 2023 $24.20 $24.31 $22.98 $23.00 609 479
Dec 22, 2023 $23.01 $24.05 $22.99 $23.94 464 216
Dec 21, 2023 $23.27 $23.53 $22.72 $22.87 380 007
Dec 20, 2023 $23.83 $23.87 $23.01 $23.06 480 356
Dec 19, 2023 $23.45 $23.99 $23.45 $23.81 530 032
Dec 18, 2023 $23.16 $23.52 $22.88 $23.25 467 143
Dec 15, 2023 $23.46 $23.79 $22.93 $23.24 933 193
Dec 14, 2023 $23.17 $23.80 $22.95 $23.24 748 412
Dec 13, 2023 $22.14 $22.84 $21.79 $22.76 623 379
Dec 12, 2023 $21.84 $22.56 $21.58 $22.00 886 558
Dec 11, 2023 $22.11 $22.79 $21.59 $21.93 626 380
Dec 08, 2023 $23.05 $23.14 $22.02 $22.05 376 894
Dec 07, 2023 $22.56 $23.16 $22.37 $23.14 361 178
Dec 06, 2023 $22.66 $23.05 $22.35 $22.55 404 680
Dec 05, 2023 $22.83 $23.12 $22.48 $22.53 368 402
Dec 04, 2023 $22.83 $23.23 $22.50 $23.07 290 645
Dec 01, 2023 $22.14 $22.92 $21.53 $22.90 324 058
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT